Boeing Company (The) (BA) › Analysis

Boeing Company (The) (BA) analysis, July 28, 2026

Published July 28, 2026 · BA chart, levels and live analysis

Executive Summary

Boeing shares advanced 3.89% to $220.32 since the July 24 report, building on the prior rebound and extending the recovery from a five-report losing streak. The move was catalyzed by second-quarter 2026 earnings that beat revenue and free cash flow expectations, alongside new commercial orders and continued production ramp momentum. The investment thesis remains centered on operational turnaround execution, with near-term financial metrics showing mixed but directionally positive progress.

Key Updates

Since the July 24 report, Boeing has reported Q2 2026 results and announced multiple aircraft agreements, reversing the previous downtrend. The company posted revenue of $24.56 billion, up 8% year over year and ahead of the $24.25 billion consensus, while generating $631 million in free cash flow versus an expected cash burn of $177 million. Commercial aircraft deliveries rose 14% year over year to 171 units in the quarter. However, the adjusted loss per share of $0.76 was wider than the $0.30 expected, partly driven by a $280 million charge on the delayed Air Force One program. Net loss narrowed to $428 million from $612 million in the prior-year period. Separately, Boeing announced purchase agreements with MSC Air Cargo (five 777-8 freighters), Uganda Airlines (four 737-8 and four 787-9 aircraft), and Luxair (two converted 737-10 firm orders with options for two more). Management reiterated that financial stabilization is the priority, with CEO Kelly Ortberg indicating the company needs "a couple more years" to repair finances before launching a new commercial aircraft and expects readiness to fund a new program by 2030.

Current Trend

Boeing shares are up 1.47% year to date, with the current price of $220.32 representing a recovery from the mid-July low near $207.82. The stock has gained 7.58% over the past five sessions and 4.17% on the day, suggesting near-term buying momentum. The six-month performance remains negative at -8.80%, indicating the recovery is still partial relative to longer-term weakness. The July 17–21 period established a near-term support zone around $207–$212, while the current level approaches resistance near the $220–$222 range. A sustained move above $220 would target higher resistance, whereas failure to hold $212 risks a retest of the recent lows.

Investment Thesis

The investment thesis rests on Boeing’s ability to execute an operational turnaround under CEO Kelly Ortberg, characterized by production rate recovery, certification of delayed programs (737 Max 7, Max 10, and 777X), free cash flow inflection, and defense portfolio stability. The company is expanding 737 Max production to a second line in Everett with a target of 52 aircraft per month, up from the FAA-cleared rate of 47. With a backlog of roughly 6,200 to nearly 7,000 aircraft and record commercial orders, demand visibility is substantial. However, the thesis requires evidence of sustained profitability and balance sheet repair before a new aircraft program can be contemplated. Market-wide demand for commercial aviation remains supportive, though airline customers are currently prioritizing reliability of existing fleets over new model development.

Thesis Status

The thesis is marginally improving but remains in the early stages of validation. The Q2 revenue beat and positive free cash flow support the stabilization narrative, while the wider-than-expected adjusted loss and Air Force One charge underscore lingering execution risks. The new order announcements from MSC Air Cargo, Uganda Airlines, and Luxair reinforce demand, but the absence of major Farnborough order headlines and management’s caution on new program timing suggest the turnaround is progressing slower than optimists had hoped. The stock’s rebound from $207.82 to $220.32 reflects relief on cash flow and production metrics rather than a fundamental re-rating.

Key Drivers

Technical Analysis

The stock has broken above the $212 resistance that capped the prior three reporting periods, establishing a near-term higher low at $207.82. The 5-day gain of 7.58% and 1-day gain of 4.17% indicate short-term momentum, likely driven by earnings relief. The YTD performance at +1.47% is modestly positive, with the six-month decline of -8.80% showing the broader trend remains under repair. Immediate support is now the $212–$215 zone, with secondary support at $207. Resistance is layered near $222–$225, corresponding to prior consolidation areas. Volume associated with the earnings move will be critical to assess conviction.

Bull Case

Bear Case

>

Get a message when the BA picture changes — the agent team watches the levels and the news for you.Create a free account

More BA analyses